Challenges in Creating and Distributing Mobile Health Tools: Q&A with Dr. Heather Evans of mPOWEr

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.


You may also like

Gilead Test Drives A-Alpha Bio Platform to Find Long-Acting Biologics Against HIV
Vaccine Communication: Another Opportunity for Biopharma to Lead
Facing the Consequences of a Misinformation Pandemic
Baseball Comes to Surprise Medical Billing